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Summary: Comparison of the indicative systems yeast glucose-6-phosphate dehydrogenase/NADP+, leuconostoc
glucose-6-phosphate dehydrogenase/NADP+ and leuconostoc glucose-6-phosphate dehydrogenase/NAD+ showed
excellent correlation and no differences in apparent creatine kinase activity with the two methods using NADP+. By
using NAD+ with the leuconostoc enzyme relative recovery of apparent creatine kinase activity is lower due to inter-
ference of other serum constituents. The mean value of the relative differences versus methods using NADP* was
5.8% in our experiments.
Abhängigkeit der Kreatinkinase-Aktivität vom gewählten Indikator-System
Kreatinkinase-Aktivität im Serum, 7. Mitteilung
Zusammenfassung: Der Vergleich der Indikator-Systeme Hefe-Glucose-6-phosphat-dehydrogenase/NADP+,
LeMCö/20sroc-Glucose-6-phosphat-dehydrogenase/NADP+ undLeMco«<9sr<9C-Glucose-6-phosphat-dehydrogenase/NAD+
zeigte für die zwei Indikator-Systeme mit NADP+ eine vorzügliche Korrelation zwischen den Methoden und keine
methodischen Differenzen bezüglich der Kreatinkinase-Aktivität. Bei Verwendung des Leuconostoc-G\ucose-6-
phösphat-dehydrogenase/NAD+-Systems wird im Vergleich zum Hefe-Glucose-6-phosphat-dehydrogenase/NADP+-
Systern eine geringere Kieatinkinase-Aktivität gefunden. Dies wird auf den Einfluß anderer Serumbestandteile zurück-
geführt. Nach unseren Ergebnissen findet im Mittel das NADP+-System 5,8% mehr.
Introduction selection of N-acetyl-cysteine as reactivating thiol to be
' , ^ , .x , published in Clinical Chemistry.In a series of publications Gabor Szasz (1-6) submitted
detailed information on the background of the studies Coenzyme specificities of glucose-6-phosphate dehydro-
on oreatine kinase activity determination in serum genäse preparations from yeast and leuconostoc species
leading to common recommendations of some national are different (12). The yeast enzyme is strongly specific
societies for Clinical Chemistry. (7-11) When Gabor for NADP+ whereas the leuconostoc enzyme can use
Szasz died a cooperative study on the influence of both NADP+ and NAD+, the latter with lower affinity
different indicating systems was running in Gießen, (l 3). As most dehydrogenases which might be present
Bern and Tutzing. The results reported here .complete in human sera with higher activities are specific toward
the series, together with an review on the reasons for the NAD+/NADH, enhanced interference was expected sub-
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stituting NADP"1" by NAD* in creatine kinase assays
(14,15).
Materials and Methods
Ad e no sine diphosphate, adenosine monophosphate, diadenosine
pentaphosphate, N-acetyl-cysteine, creatine phosphate, glucose
and hexokinase were dissolved to a common stock solution of
10% higher concentrations as compared to the recommended
methods in imidazole buffer pH 6,7 containing 2 mmol/1 EDTA.
To each 90 ml of this stock solution were added:
for method 1:
0,438 g NADP*, disodium salt and 440 U yeast glucose-6-phos-
phate dehydrogenase
for method 2:
0,438 g NADP* disodium salt and 440 U leuconostoc glucose-
6-phosphate dehydrogenase.
for method 3:
0,354 g NAD*, free acid and 440 U leuconostoc glucose-6-
phosphate dehydrogenase.
These assay solutions were brought to 100 ml by addition of
water and used the same day for creatine kinase assays. All
reagents were from Boehringer Mannheim GmbH. The samples
were stored at + 4 °C and assayed on the day of collection.
Results
65 samples with creatine kinase activity above 40 U/l
were assayed with all 3 methods.
Figure 1 shows the excellent correlation of yeast glucose-
6-phosphate dehydrogenase/NADP"1" versus leuconostoc
glucose-6-phosphate dehydrogenase/N ADP* .
Figure 2 shows the relative differences of the methods as
a function of creatine kinase activity obtained with
method 1 (yeast glucose-6-phosphate dehydrogenase/
NADP+).
In table 1 the differences found are tabulated.
Figure 3 gives the correlation between yeast glucose-6-
phosphate dehydrogenase/NADP+ versus leuconostoc
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Fig. 1. Diagram of pairs of measured values.
Method 1: yeast glucose-6-phosphate dehydrogenase
1.7 3 kU/1 assay volume. NADP*: 2 mmol/L
Method 2: leuconostoc glucose-6-phosphate dehydro-
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Fig. 2. Relative differences of rnethods.
(method l - method 2) · 100/method l as related to
shown glucose-6-phosphate dehydrogenase activities found
with method 1.
Method 1: yeast glucose-6^phosphate dehydrogenase
1.73 kU/1 assay volume. NADP*: 2 mmol/1.
Method 2: leuconostoc glucose-6-phosphate dehydrogenase
1.7 3 kU/1 assay volume. NADP*: 2 mmol/1.
Tab. 1. Differences found between method 1 and method 2.
Relative Differences Absolute differences
of methods of methods
(method 1 - method 2) * 100
method 1
(method 1 - method 2)
Mean value - 0,8 % - 4,3 U/l
Differencemin. _j 2)Q % -5 1 ,0 U/l
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Fig. 3. Diagram of pairs of measured values.
Method 1: yeast glucose-6-phosphate dehydrogenase
1.73 kU/1 assay volume. NADF: 2 mmol/1.
Method 3: leuconostoc glucose-6-phosphate dehydro-
genase: 1.73 kU/1 assay volume. NAD*: 2 mmpl/1.
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Tab. 2. Differences found between method 1 and method 3.
Relative Differences Absolute differences
of methods of methods
(method 1 - method 3) · 100
method 1
(method 1 - method 3)
30J-
Mean value 5,8 %





glucose-6-phosphate dehydrogenase/NAD*. It is seen
that with the NAD+-system lower values result as com-
pared to NADP*. These relative differences of methods
are shown in figure 4 as a function of method 1 (yeast
glucose-6-phosphate dehydrogenase/NADP*). They are
tabulated in table 2.
Relative differences between method 1 and 2 for all
- except two values - are < 10% with a mean value
of -0.8% only, whereas relative differences between
method 1 and 3 scatter widely from - 5 to + 20% with a
mean value of 5.8% higher activity of the yeast glucose-
6-phosphate dehydrogenase/NADP*-system. This
magnitude of difference in methods using NAD+ com-
pared to methods with NADP* was expected and is
attributable to interfering enzymes in serum, e.g. l^ctate
dehydrogenase. We therefore recommend the use pf
NADP+ with either yeast or leuconostoc glycp§e-6-phos-
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Fig. 4. Relative differences of methods (method 1-method 3)
• 100/method 1 shown as related to activities found with
method 1.
Method 1: yeast glucose-6-phosphate dehydrogenase
1.73 kU/1 assay volume NADP+: 2 mmol/1.
Method 3: leuconostoc glucose-6-phosphate dehydro-
genase: 1.73 k U/l assay volume NAD"1": 2 mmol/1
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Aussagen über das Risiko arteriosklerotischer Gefäß-
erkrankungen sind durch die-Bestimmung des Gesamt-
cholesterins und der Triglyceride im Serum möglich;
darum sind'dieseTbeiden Bestimmungen als Basis-
programm der Lipiddiagnostik anzusehen. Die zusätzliche
Bestimmung des HDL-Cholesterins erlaubt jedoch eine
fundiertere diagnostische Aussage. Zahlreiche neuere
Studien belegen, daß Patienten mit einem hohen
HDL-Cholesterin-Spiegel ein geringeres Risiko für die
Entwicklung von Arteriosklerose und koronaren Herz-
krankheiten, solche mit einer niedrigen HDL-Cholesterin-
Konzentration ein erhöhtes Risiko besitzen. op=J
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